Topical Diphencyprone as an Effective Treatment for Cutaneous Metastatic Melanoma

참고문헌 (10)

1. Garbe C, "Melanoma epidemiology and trends", Clin Dermatol, 27, pp.3~9 (2009)
2. Gasent Blesa JM, "Melanoma: from darkness to promise", Am J Clin Oncol, 34, pp.179~187 (2011)
3. Wilgenhof S, "Restoration of tumor equilibrium after immunotherapy for advanced melanoma: three illustrative cases", Melanoma Res, 21, pp.152~159 (2011)
4. Good LM, "Intralesional agents in the management of cutaneous malignancy: a review", J Am Acad Dermatol, 64, pp.413~422 (2011)
5. Holzer AM, "Haptens as drugs: contact allergens are powerful topical immunomodulators", J Drugs Dermatol, 5, pp.410~416 (2006)
6. Damian DL, "Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone", J Am Acad Dermatol, 56, pp.869~871 (2007)
7. Damian DL, "Topical diphencyprone immunotherapy for cutaneous metastatic melanoma", Australas J Dermatol, 50, pp.266~271 (2009)
8. Harland CC, "Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine", Lancet, 2, pp.445~ (1989)
9. Trefzer U, "Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma", Dermatology, 211, pp.370~371 (2005)
10. Martiniuk F, "TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone", J Drugs Dermatol, 9, pp.1368~1372 (2010)

관련 논문AI추천